Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migalastat
migalastat
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
Endpoints
Fri, 12/15/17 - 09:33 am
Amicus
Pharma CEOs
FDA
Scott Gottlieb
migalastat
Fabry disease
Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track
Endpoints
Tue, 09/19/17 - 09:22 am
FDA
Amicus Therapeutics
migalastat
Fabry disease
fast track
FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug
Forbes
Tue, 07/11/17 - 09:53 am
FDA
Amicus Therapeutics
Rare Diseases
Fabry disease
migalastat
Amicus' Fabry disease drug gets European Commission approval
Yahoo/Reuters
Tue, 05/31/16 - 09:52 am
Amicus Therapeutics
Fabry's disease
Europe
migalastat
On second thought, Amicus won't be filing its lead drug this year
Fierce Biotech
Fri, 10/2/15 - 10:45 am
Amicus
FDA
migalastat
Fabry's disease
Amicus' rare disease drug lines up for a quick EU approval
Fierce Biotech
Tue, 05/26/15 - 09:52 am
Amicus
Europe
migalastat
Fabry's disease